NJ S2990

Long-term care facilities in New Jersey must have a consultant pharmacist and either a provider pharmacist or director of pharmaceutical services (for in-house pharmacies), all of whom must be New Jersey licensed.

Each facility must establish an interdisciplinary pharmacy and therapeutics committee consisting of the administrator, nursing staff representative, and consultant pharmacist, with quarterly meetings required.

Consultant pharmacists must be independent from the director of pharmaceutical services and provider pharmacist, and must attest they have no affiliation with either to prevent conflicts of interest.

Facilities keeping emergency injectable or oral controlled substances must maintain current DEA and controlled dangerous substance registrations for that location.

The Commissioner of Health will adopt implementing regulations, with the law taking effect immediately upon passage.